Publications by authors named "Edinger Matthias"

Claim this Profile
I
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party.
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, Christophe Peczynski, Jan Maciej Zaucha, Matthias Stelljes, Matthias Edinger

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia.
Klaus Wethmar, Matthias Edinger, Kerstin Schäfer-Eckart, Matthias Stelljes, Thomas Schroeder

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"The antibiotic paradox" in allogeneic stem cell transplantation.
Daniela Weber, Elisabeth Meedt, Sakhila Ghimire, Andreas Hiergeist, Michael A G Kern, Matthias Höpting, Matthias Edinger

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT.
Kordelia Barbullushi, Myriam Labopin, Nicolaus Kröger, Jürgen Finke, Matthias Stelljes, Matthias Edinger

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury.
Julius C Fischer, Sascha Göttert, Maximilian Giller, Paul Heinrich, Kaiji Fan, Matthias Edinger

Signal Transduct Target Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.
Ekin Ece Gurer Kluge, Elisabeth Meedt, Julia Feicht, Kedi Cao, Andreas Hiergeist, Matthias Hoepting, Matthias Evert, Matthias Edinger

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration.
Sascha Göttert, Erik Thiele Orberg, Kaiji Fan, Paul Heinrich, Diana M Matthe, Matthias Edinger, Matthias Evert

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder.
Helena Hansmann, Chiara Henkel, Matthias A Fante, Dennis C Harrer, Stefanie Heidemanns, Matthias Edinger

Am J Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis.
Silke Heidenreich, Katharina Egger-Heidrich, Jörg P Halter, Lasse Jost, Friedrich Stölzel, Matthias Edinger, Matthias A Fante

Bone Marrow Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.
Jesús Duque-Afonso, Jürgen Finke, Maud Ngoya, Jacques-Emmanuel Galimard, Johannes Schetelig, Matthias Eder, Matthias Edinger, Matthias Stelljes

Bone Marrow Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany.
Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig, Matthias Stelljes, Matthias Eder, Matthias Edinger

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.
Markus Perl, Konstantin Herfeld, Dennis C Harrer, Matthias Höpting, Marina Schweiger, Matthias Edinger, Matthias A Fante

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis.
Alexander Denk, Cornelia Mittermaier, Daniela Weber, Matthias Fante, Sibel Güneş, Matthias Edinger

Ann Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis.
Alexander Denk, Matthias Edinger, Daniela Weber, Ernst Holler, Matthias Fante

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients.
Ana F David, Andreas Heinzel, Michael Kammer, Constantin Aschauer, Roman Reindl-Schwaighofer, Matthias Edinger

EBioMedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligoclonal CD4CXCR5 T cells with a cytotoxic phenotype appear in tonsils and blood.
Chunguang Liang, Silvia Spoerl, Yin Xiao, Katharina M Habenicht, Sigrun S Haeusl, Matthias Edinger

Commun Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation.
Julia Winkler, Hannes Tittlbach, Andrea Schneider, Ingrid Vasova, Julian Strobel, Matthias Edinger

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host disease.
David J Dittmar, Franziska Pielmeier, Nicholas Strieder, Alexander Fischer, Michael Herbst, Matthias Edinger

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary solid malignancies and precancerous lesions after allogeneic hematopoietic stem cell transplantation using non-total body irradiation-based conditioning in acute myeloid leukemia.
Gruber Isabella, Appel Katharina, Edinger Matthias, Koelbl Oliver, Wolff Daniel

J Cancer Res Clin Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease-an analysis from transplant centers across Europe.
Ronja Langer, Antonela Lelas, Michael Rittenschober, Agnieszka Piekarska, Alicja Sadowska-Klasa, Matthias Grube, Matthias Edinger

Front Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation.
Erik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, Jinling Xue, Paul Heinrich, Matthias Edinger

Nat Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis.
Jana Doering, Markus Perl, Daniela Weber, Bernhard Banas, Christian Schulz, Matthias Edinger, Matthias A Fante

Transplant Cell Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
Daniela Weber, Andreas Hiergeist, Markus Weber, Sakhila Ghimire, Bernd Salzberger, Matthias Edinger

Clin Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, Martin Bornhäuser, Rose-Marie Hamladji, Matthias Edinger

Bone Marrow Transplant· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia.
Isabella Gruber, Oliver Koelbl, Marius Treutwein, Florian Zeman, Wolfgang Herr, Matthias Edinger

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis